For example, luminal breast cancer is generally associated with low expression of ACSL4 (Doll et al., 2017), and some breast cancer cells upregulate prominin2 expression to promote iron excretion in the form of ferritin, rendering such cells resistant to ferroptosis (Brown et al., 2019). This evidence concerns the gene ACSL4 and breast cancer.